Creative Planning’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Creative Planning’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,200	Closed	-$1K	–	2161
2019 Q4	$1K	Buy	+1,200	New	+$135K	﹤0.01%	1996
2019 Q3	–	Sell	-100	Closed	-$2K	–	2142
2019 Q2	$2K	Sell	100 -200	-67%	-$34.6K	﹤0.01%	1983
2019 Q1	$2K	Buy	+300	New	+$44.6K	﹤0.01%	1945
2018 Q4	–	Sell	-1,000	Closed	-$35K	–	2166
2018 Q3	$35K	Buy	1,000 +400	+67%	+$57.7K	﹤0.01%	1909
2018 Q2	$11K	Buy	600 +300	+100%	+$42.6K	﹤0.01%	1947
2018 Q1	$3K	Buy	+300	New	+$37.7K	﹤0.01%	1980
2016 Q3	–	Sell	-200	Closed	-$2K	–	4800
2016 Q2	$2K	Buy	+200	New	+$16.8K	﹤0.01%	4084
2014 Q3	–	Sell	-900	Closed	-$10K	–	4215
2014 Q2	$10K	Buy	+900	New	+$62.6K	﹤0.01%	2891

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Creative Planning's GWPH Position: Q2 2021 in Review

Creative Planning sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 4,034 shares — an estimated $875K sold.

Creative Planning first reported a position in GWPH in Q1 2014 and held it in 28 quarters. The position peaked at $1.26M in Q1 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Creative Planning reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Creative Planning sold 4,034 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $875K.
Creative Planning first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and held it in 28 quarters.
Creative Planning's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.26M in Q1 2019.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Creative Planning's 13F filing for Q2 2021, filed 4 Aug 2021.